American College of Toxicology


= Members Only

Educational Courses

Practical Application of Toxicology in Drug Development

Co-Sponsored with Charles River and in association with the British Toxicology Society

Course Description

This course, taught by distinguished experts, is designed to provide a basic training in toxicology. Participants will obtain an overall understanding of the principles of nonclinical safety evaluation with emphasis on the practical application of these principles and interpretation of nonclinical safety data. The course will include discussion of regulatory case studies and a workshop. This toxicology course is intended to benefit individuals working with small and large molecules from biotechnology and pharmaceutical companies, along with those from Contract Research Organizations and regulatory agencies who are interested in toxicology. Regulatory toxicology in drug development will be emphasized, particularly from the European perspective.

Course Flyer

Course Schedule

Monday, September 15

Basic Principles of Toxicology, A. Wallace Hayes, Harvard
Pharmacology, Rob Wallis, Safety Pharmacology Consultant
Safety Pharmacology, Rob Wallis, Safety Pharmacology Consultant
Toxicology Methods/General Tox, Adam Woolley, ForthTox
Regulatory Toxicology, David Jones, MHRA

Tuesday, September 16

Organ Systems, John Foster, Senior Consultant Pathologist
Clinical Pathology, Malcolm York, GlaxoSmithKline
Pathology, Peter Greaves, MRC Toxicology Unit

Wednesday, September 17

Reproduction/Developmental Toxicology, Gary Chellman, Charles River
Pharmacokinetics/ADME, Gerry Kenna, Safety Science Consultant
Genetic Toxicology, George Johnson, Swansea University
Carcinogenicity, Nigel Roome, Sanofi

Thursday, September 18

Safety of Biotechnology Products, Jennifer Sims, Integrated Biologics
Immunotoxicology, Ian Kimber, University of Manchester
Risk Assessment, Ernie Harpur, Newcastle University
Regulatory Case Studies
Kenneth Hastings, Sanofi US

Friday, September 19

Nonclinical Assessment of Drug A:
A Special Workshop of Drug Development from Regulatory Perspective

Kenneth Hastings, Sanofi US
Jennifer Sims, Integrated Biologics

Monday through Thursday¬† 8:00 AM–5:00 PM
Friday 8:00 AM–12:00 Noon

Program Committee:
Ernie Harpur, Newcastle University
Hanan Ghantous, US FDA
Norman Kim, Biogen Idec

Karen McCusker, Charles River
Jamie Wilton, Charles River


Online Registration

Registration Form PNP Reg Form

Space is limited to 60 attendees—register early

  By September 12
ACT and BTS Member Registration


Nonmember Registration


Government Registration


Student (Full Time) Registration


Group Nonmember Registration
(Three or More from Same Organization*)


Group Member Registration
(Three or More from Same Organization*)


* In order to take advantage of this discounted rate, registration form(s) should be returned to ACT Headquarters for processing.

Note: Payments will be processed in US $.

Refund Policy:

  • £50 Processing Fee will be charged before June 28, 2013.
  • 50% refund if canceled before July 26, 2013.
  • After July 26, 2013, no fees will be refunded.


The course is held at:
Crowne Plaza Edinburgh
The Roxburghe
38 Charlotte Square
Edinburgh EH2 4HQ
United Kingdom
+44 (0)844.879.9063

For lodging, make arrangements directly with the hotel above, mentioning that you are participating in the course.

Housing Deadline: Friday, August 15

Alternative Housing Options

Premier Inn, Edinburgh Princes Street
Distance: 0.1 miles

Travelodge Edinburgh Central Princess Street Hotel
Distance: 0.4 miles

Travelodge Edinburgh Central Queen Street Hotel
Distance: 0.4 miles

Mercure, Edinburgh City
Distance: 0.5 miles

Holiday Inn Express, Edinburgh City Centre
Distance: 1.0 mile

Join or Renew ACT membership
11190 Sunrise Valley Drive, Suite 300, Reston, Virginia 20191
Tel: 703.547.0875 | Fax: 703.438.3113 | Email:

Copyright © 2021 American College of Toxicology. All rights reserved.
You may view the ACT Privacy Policy, provide consent to ACT to email you communications or unsubscribe to stop receiving further ACT communication. Privacy Policy | Code of Conduct | Provide Consent | Unsubscribe